Class 4 Medicines Defect Notification: Doncaster Pharma Limited, Hiprex 1g tablets, EL(26)A/20
Doncaster Pharma Limited has issued a Class 4 Medicines Defect Notification to the MHRA regarding a significant error in the Braille embossing on the outer packaging of specific parallel imported batches of Hiprex 1 g tablets (POM). This defect could potentially lead to confusion for visually impaired patients relying on the Braille labeling for accurate…









